Skip to content
Search

Latest Stories

Submit Guest Post

Ibuprofen may not harm COVID-19 patients as previously claimed: Study

There is no evidence for or against the use of anti-inflammatory drugs such as ibuprofen for patients with COVID-19, according to a study which assessed existing studies on other coronavirus strains as well as the limited literature on the current pandemic.

According to the researchers, including those from King's College London in the UK, other types of drugs, such as TNF blockers and JAK inhibitors are safe to use.


The research, published in the journal ecancermedicalscience, assessed 89 existing studies on other coronavirus strains such as MERS and SARS, as well as ones on the current pandemic to find out if certain medications used in people already suffering from diseases should be avoided if they catch COVID-19.

It said some patients, such as those with cancer, are already given immunosuppressive drugs to lower the body's immune response, or immunostimulant drugs to boost it.

If these patients then catch COVID-19 doctors need to know what medication to stop, the researchers explained.

"This pandemic has led to challenging decision-making about the treatment of COVID-19 patients who were already critically unwell," said Mieke Van Hemelrijck, a cancer epidemiologist and an author on the study.

"In parallel, doctors across multiple specialties are making clinical decisions about the appropriate continuation of treatments for patients with chronic illnesses requiring immune suppressive medication," Hemelrijck said.

While there had been some speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen might make the symptoms worse for some COVID-19 patients, the researchers said they did not find evidence to support this statement.

"Current evidence suggests that low dose prednisolone (a steroid used to treat allergies) and tacrolimus therapy (an immunosuppressive drug given to patients who have had an organ transplant) may have beneficial impact on the course of coronavirus infections. However further investigation is needed," said study co-author Sophie Papa.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Suranne Jones reveals how menopause is affecting her acting career: 'You can't remember your lines'

The 48-year-old actress said everyone on the Doctor Foster set knew she was going through menopause

Getty Images

Suranne Jones reveals how menopause is affecting her acting career: 'You can't remember your lines'

Highlights

  • Suranne Jones says menopause-related brain fog has made it harder to remember her lines.
  • The 48-year-old actress said everyone on the Doctor Foster set knew she was going through menopause.
  • Jones is returning for the third and final series of the BBC thriller, nine years after its second season ended.
  • She has also reflected on ending her role in Vigil and entering a new phase of her career.

Suranne Jones has opened up about how menopause is affecting her acting career, revealing that brain fog has made it difficult to remember her lines while working on set.

The 48-year-old actress, who is returning for the third and final series of BBC thriller Doctor Foster, said the impact on her memory had been particularly challenging in a profession that requires her to learn scripts.

Keep ReadingShow less